Metabolic Derangement in Non-Alcoholic Fatty Liver Disease: Opportunities for Early Diagnostic and Prognostic Markers

Verma Abhinav,Rishabh Mittal,Mathiyazhagan Navaneethakannan,Ahirwar Sonu Singh,Mukherjee Sukhes,Kotnis Ashwin
DOI: https://doi.org/10.2174/0115665240269082240213115711
2024-02-22
Current Molecular Medicine
Abstract:Abstract: Non-alcoholic fatty liver disease is a globally prevalent disorder that can rapidly progress if not detected early. Currently, no accepted markers exist for early diagnosis and prognosis of NAFLD. This review describes derangement in major metabolic pathways of lipid, carbohydrate, and amino acids in NAFLD. It suggests that measuring levels of thrombospondin, TyG index, asymmetric dimethylarginine, LAL-A, GLP-1, FGF-21, and GSG index are potential markers for early diagnosis of NAFLD. A single marker may not indicate early NAFLD, and further large-scale studies on correlating levels of Thrombospondin-2, triglyceride-glucose index, and FGF-21 with NAFLD are warranted.
medicine, research & experimental
What problem does this paper attempt to address?